Sees 2026 Revenue at $700M-$720M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 24 2026
0mins
Sees 2026 revenue $700M-$720M vs. $701.2M in 2025.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AVNS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AVNS
About AVNS
Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes Nexus TKO, an anti-reflux needleless connector technology. The Pain Management and Recovery is a portfolio of non-opioid pain solutions including surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems, as well as Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies
- Targeted Companies: Halper Sadeh LLC is investigating Avanos Medical, Inc., Nuvalent, Inc., XOMA Royalty Corporation, and TruBridge, Inc. for potential violations of federal securities laws or breaches of fiduciary duties, including Avanos's sale to American Industrial Partners for $25.00 per share.
- Shareholder Rights: Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options, with the firm offering to handle matters on a contingent fee basis, emphasizing its commitment to protecting shareholder interests.
- Potential Benefits: The investigation may lead to increased consideration or additional disclosures for shareholders, indicating Halper Sadeh LLC's dedication to securing better financial outcomes and transparency for investors.
- Legal Advocacy: Halper Sadeh LLC represents investors globally, focusing on securities fraud and corporate misconduct cases, having successfully recovered millions for defrauded investors, showcasing its expertise in safeguarding investor rights.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the acquisition of Taylor Morrison Home Corp. by Berkshire Hathaway, with shareholders expected to receive $72.50 per share in cash, potentially providing significant financial returns for investors.
- Caesars Entertainment Transaction: In the deal with Fertitta Gaming Holdco, Caesars shareholders are anticipated to receive $31.00 per share in cash along with a ticking consideration, which could enhance shareholder returns over time.
- XOMA Shareholder Gains: XOMA Royalty Corporation's sale to Ligand Pharmaceuticals will see shareholders receiving $39.00 per share in cash, offering a clear and immediate financial benefit to investors.
- Avanos Medical Acquisition: Avanos Medical, Inc. is set to provide shareholders with $25.00 per share in cash from its sale to American Industrial Partners, with a shareholder vote scheduled for July 22, 2026, to finalize the transaction.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Caesars Entertainment, Inc. (NASDAQ:CZR) regarding its sale to Fertitta Entertainment, Inc. for $31.00 per share, which may infringe on shareholder rights, prompting shareholders to consider their options.
- Shareholder Rights Protection: The firm is also scrutinizing Avanos Medical, Inc. (NYSE:AVNS) for its sale to American Industrial Partners at $25.00 per share, which could limit superior competing offers, encouraging shareholders to understand their rights.
- Global Business Travel Group: Halper Sadeh LLC is investigating Global Business Travel Group, Inc. (NYSE:GBTG) for its sale to Long Lake Management at $9.50 per share, potentially harming shareholders, and advises them to contact the firm for more information.
- Legal Fee Arrangement: The firm operates on a contingency fee basis, meaning shareholders are not responsible for legal fees upfront, aiming to provide legal support for affected investors and seek corporate reforms and compensation.
See More
Investigation Alerts for Multiple Company Acquisitions
- Avanos Medical Acquisition Investigation: Avanos Medical is set to be acquired by American Industrial Partners for $25.00 per share in a deal valued at approximately $1.272 billion, with investigations focusing on whether the board breached fiduciary duties by failing to ensure a fair process for shareholders.
- Global Business Travel Group Acquisition: Amex GBT will be acquired by Long Lake Management for $9.50 per share in an all-cash transaction valued at around $6.3 billion, with investigations examining if the board failed to conduct a fair process, potentially impacting shareholder interests.
- Equity Residential Merger Investigation: Equity Residential will merge with AvalonBay Communities, with AvalonBay shareholders receiving 2.793 shares of Equity Residential for each share owned, and investigations are looking into whether the board ensured a fair process, affecting shareholder rights.
- LiveRamp Acquisition Review: LiveRamp is to be acquired by Publicis Groupe for $38.50 per share, totaling an enterprise value of $2.167 billion, with investigations questioning if the board fulfilled fiduciary duties to ensure a fair transaction for shareholders.
See More
Investigation Alerts for Multiple Company Mergers
- Helix Merger Investigation: Helix Energy Solutions is set to be acquired by Hornbeck Offshore Services, with Helix shareholders expected to own approximately 45% of the combined entity, raising concerns about whether the Helix Board breached fiduciary duties by failing to ensure a fair process in the transaction.
- TopBuild Acquisition Details: TopBuild will be acquired by QXO, allowing shareholders to choose between $505 in cash or 20.2 shares of QXO stock per TopBuild share, with the deal's total consideration being approximately 45% cash and 55% stock, prompting investigations into whether the transaction offers fair value, especially as it falls below the 52-week high of $559.47.
- Avanos Acquisition Situation: Avanos is being acquired by American Industrial Partners for $25.00 per share, amounting to an enterprise value of approximately $1.272 billion, with investigations focusing on whether the Avanos Board failed to conduct a fair process to ensure shareholder value in the deal.
- Affinity Bancshares Transaction: Affinity Bancshares will be acquired by Fidelity for $23.00 per share, representing a total transaction value of approximately $142.8 million, with investigations examining whether the Board breached fiduciary duties by not ensuring the fairness of the transaction for shareholders.
See More
Class Action Developments for Multiple Companies' Shareholders
- XOMA Shareholder Payout: XOMA Royalty Corporation is set to be sold to Ligand Pharmaceuticals for $39.00 per share in cash, which is expected to provide substantial returns for shareholders and enhance its market appeal.
- RE/MAX Shareholder Options: Shareholders of RE/MAX Holdings, Inc. will have the choice of receiving either 5.152 shares of the combined company or $13.80 in cash per share, which will strengthen its competitive position in the real estate market.
- Galera Merger Shares: Following the merger with Obsidian Therapeutics, Inc., Galera Therapeutics, Inc. shareholders will own approximately 1.8% of the combined company, indicating its potential for integration in the biotechnology sector.
- Avanos Cash Return: Avanos Medical, Inc. is being sold to affiliates of American Industrial Partners for $25.00 per share in cash, which is expected to provide direct cash returns to shareholders and enhance its financial stability.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Targeted Companies: Halper Sadeh LLC is investigating Avanos Medical, Inc., Nuvalent, Inc., XOMA Royalty Corporation, and TruBridge, Inc. for potential violations of federal securities laws or breaches of fiduciary duties, including Avanos's sale to American Industrial Partners for $25.00 per share.
- Shareholder Rights: Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options, with the firm offering to handle matters on a contingent fee basis, emphasizing its commitment to protecting shareholder interests.
- Potential Benefits: The investigation may lead to increased consideration or additional disclosures for shareholders, indicating Halper Sadeh LLC's dedication to securing better financial outcomes and transparency for investors.
- Legal Advocacy: Halper Sadeh LLC represents investors globally, focusing on securities fraud and corporate misconduct cases, having successfully recovered millions for defrauded investors, showcasing its expertise in safeguarding investor rights.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the acquisition of Taylor Morrison Home Corp. by Berkshire Hathaway, with shareholders expected to receive $72.50 per share in cash, potentially providing significant financial returns for investors.
- Caesars Entertainment Transaction: In the deal with Fertitta Gaming Holdco, Caesars shareholders are anticipated to receive $31.00 per share in cash along with a ticking consideration, which could enhance shareholder returns over time.
- XOMA Shareholder Gains: XOMA Royalty Corporation's sale to Ligand Pharmaceuticals will see shareholders receiving $39.00 per share in cash, offering a clear and immediate financial benefit to investors.
- Avanos Medical Acquisition: Avanos Medical, Inc. is set to provide shareholders with $25.00 per share in cash from its sale to American Industrial Partners, with a shareholder vote scheduled for July 22, 2026, to finalize the transaction.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Caesars Entertainment, Inc. (NASDAQ:CZR) regarding its sale to Fertitta Entertainment, Inc. for $31.00 per share, which may infringe on shareholder rights, prompting shareholders to consider their options.
- Shareholder Rights Protection: The firm is also scrutinizing Avanos Medical, Inc. (NYSE:AVNS) for its sale to American Industrial Partners at $25.00 per share, which could limit superior competing offers, encouraging shareholders to understand their rights.
- Global Business Travel Group: Halper Sadeh LLC is investigating Global Business Travel Group, Inc. (NYSE:GBTG) for its sale to Long Lake Management at $9.50 per share, potentially harming shareholders, and advises them to contact the firm for more information.
- Legal Fee Arrangement: The firm operates on a contingency fee basis, meaning shareholders are not responsible for legal fees upfront, aiming to provide legal support for affected investors and seek corporate reforms and compensation.
See More
Investigation Alerts for Multiple Company Acquisitions
- Avanos Medical Acquisition Investigation: Avanos Medical is set to be acquired by American Industrial Partners for $25.00 per share in a deal valued at approximately $1.272 billion, with investigations focusing on whether the board breached fiduciary duties by failing to ensure a fair process for shareholders.
- Global Business Travel Group Acquisition: Amex GBT will be acquired by Long Lake Management for $9.50 per share in an all-cash transaction valued at around $6.3 billion, with investigations examining if the board failed to conduct a fair process, potentially impacting shareholder interests.
- Equity Residential Merger Investigation: Equity Residential will merge with AvalonBay Communities, with AvalonBay shareholders receiving 2.793 shares of Equity Residential for each share owned, and investigations are looking into whether the board ensured a fair process, affecting shareholder rights.
- LiveRamp Acquisition Review: LiveRamp is to be acquired by Publicis Groupe for $38.50 per share, totaling an enterprise value of $2.167 billion, with investigations questioning if the board fulfilled fiduciary duties to ensure a fair transaction for shareholders.
See More
Investigation Alerts for Multiple Company Mergers
- Helix Merger Investigation: Helix Energy Solutions is set to be acquired by Hornbeck Offshore Services, with Helix shareholders expected to own approximately 45% of the combined entity, raising concerns about whether the Helix Board breached fiduciary duties by failing to ensure a fair process in the transaction.
- TopBuild Acquisition Details: TopBuild will be acquired by QXO, allowing shareholders to choose between $505 in cash or 20.2 shares of QXO stock per TopBuild share, with the deal's total consideration being approximately 45% cash and 55% stock, prompting investigations into whether the transaction offers fair value, especially as it falls below the 52-week high of $559.47.
- Avanos Acquisition Situation: Avanos is being acquired by American Industrial Partners for $25.00 per share, amounting to an enterprise value of approximately $1.272 billion, with investigations focusing on whether the Avanos Board failed to conduct a fair process to ensure shareholder value in the deal.
- Affinity Bancshares Transaction: Affinity Bancshares will be acquired by Fidelity for $23.00 per share, representing a total transaction value of approximately $142.8 million, with investigations examining whether the Board breached fiduciary duties by not ensuring the fairness of the transaction for shareholders.
See More
Class Action Developments for Multiple Companies' Shareholders
- XOMA Shareholder Payout: XOMA Royalty Corporation is set to be sold to Ligand Pharmaceuticals for $39.00 per share in cash, which is expected to provide substantial returns for shareholders and enhance its market appeal.
- RE/MAX Shareholder Options: Shareholders of RE/MAX Holdings, Inc. will have the choice of receiving either 5.152 shares of the combined company or $13.80 in cash per share, which will strengthen its competitive position in the real estate market.
- Galera Merger Shares: Following the merger with Obsidian Therapeutics, Inc., Galera Therapeutics, Inc. shareholders will own approximately 1.8% of the combined company, indicating its potential for integration in the biotechnology sector.
- Avanos Cash Return: Avanos Medical, Inc. is being sold to affiliates of American Industrial Partners for $25.00 per share in cash, which is expected to provide direct cash returns to shareholders and enhance its financial stability.
See More
